This Month's Supplements

 
 

@RetinaToday

http://t.co/Q414Uwij3L > 5Q with Thomas R. Friberg, MD > http://t.co/sQLketsUUR

Articles From This Issue


 

Innovation in Retina: A Win For Our Patients

CHIEF MEDICAL EDITORS’ PAGE

There is an adage that “necessity is the mother of invention.” If that is true, then there must have been many needs in retina medicine not too long ago, because we a…

Inside a Hostile Takeover Battle

NEWS FEATURE

Allergan and Valeant Pharmaceuticals International are two major companies that are similar in size but have very different backgrounds, business models, and philosophies. Bot…

 
Uveitis Resource Center

advertisement

NEWS


 

Advance of Macular Degeneration Can be Predicted by Retinal-Scan Analysis

Stanford University School of Medicine scientists have found a new way to forecast which patients wi…

RetroSense Therapeutics Granted Orphan Drug Designation for Lead Product RST-001 for Retinitis Pigmentosa

RetroSense Therapeutics LLC announced that the FDA has granted orphan drug designation for the compa…

Video Series


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Bryan Bechtel
Editor-in-Chief
484-581-1827
bbechtel@bmctoday.com

Alan B. Guralnick
Publisher
484-581-1832
aguralnick@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.

Website Design by Sides Media